Literature DB >> 14731312

Acute augmentation of serotonin suppresses cardiovascular responses to emotional valence.

Andrew H Kemp1, Pradeep J Nathan.   

Abstract

A key component in visceral reactivity to emotional states is heart rate (HR), however little is known about how HR response to emotional stimuli is modulated by neurochemicals. The present study investigated the way in which acute enhancement of serotonin (5-HT) function with a selective serotonin reuptake inhibitor (SSRI) modulates the HR associated with differently valent images (pleasant, neutral, unpleasant). Sixteen healthy participants viewed 75 images whilst HR was recorded. Participants were tested under two single-dose treatment conditions: placebo and citalopram (20 mg). Our findings suggest: (1) HR is able to differentiate differently valent images during placebo treatment and, (2) administration of citalopram suppresses the differences in HR between differently valent images. These results suggest that 5-HT may modulate the cardiovascular HR response to visual emotional stimuli and indicate that 5-HT may have a protective effect on the cardiovascular responses to emotional stimuli.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14731312     DOI: 10.1017/S1461145703003894

Source DB:  PubMed          Journal:  Int J Neuropsychopharmacol        ISSN: 1461-1457            Impact factor:   5.176


  3 in total

1.  Impact of escitalopram on vagally mediated cardiovascular function in healthy participants: implications for understanding differential age-related, treatment emergent effects.

Authors:  Andrew H Kemp; Tim Outhred; Sasha Saunders; Andre R Brunoni; Pradeep J Nathan; Gin S Malhi
Journal:  Psychopharmacology (Berl)       Date:  2013-12-15       Impact factor: 4.530

2.  The CRH1 antagonist GSK561679 increases human fear but not anxiety as assessed by startle.

Authors:  Christian Grillon; Elizabeth Hale; Lynne Lieberman; Andrew Davis; Daniel S Pine; Monique Ernst
Journal:  Neuropsychopharmacology       Date:  2015-03-13       Impact factor: 7.853

3.  The impact of escitalopram on vagally mediated cardiovascular function to stress and the moderating effects of vigorous physical activity: a randomized controlled treatment study in healthy participants.

Authors:  Camilla S Hanson; Tim Outhred; Andre R Brunoni; Gin S Malhi; Andrew H Kemp
Journal:  Front Physiol       Date:  2013-09-24       Impact factor: 4.566

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.